Back to Trades
Venkatesan Jay
DirectorCIK 0001413350
Profile
- Filings
- 3
- Buy transactions
- 1
- Sell transactions
- 0
- Companies
- 1
- Active
- 2025–2026
Venkatesan Jay, Director, has filed 3 SEC reports (2025–2026), all concentrated in Serina Therapeutics, Inc. (SER), totaling $1.1M in disclosed volume. Weighing $1.0K bought versus $0 sold, the history is heavily weighted toward buying. The largest single open-market purchase on record is $1.0K in Serina Therapeutics, Inc.. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
3 loaded
| Jun 22 | SER Serina Therapeutics, Inc. | Venkatesan Jay | Director | Buy | $1.0K |
| Apr 21 | SER Serina Therapeutics, Inc. | Venkatesan Jay | Director | Grant | $14.7K |
| Nov 10 | SER Serina Therapeutics, Inc. | Venkatesan Jay | Director | Award | $39.1K |
3 filings